Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab and manufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 14, 2021 | Seed | $26M | 1 | Kineticos Disruptor Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kineticos Disruptor Fund | Yes | Seed |